Posts - CLL Support | HealthUnlocked
All posts for November 2015
Adventures with Idelalisib - a ruptured spleen - (Part One)
Hi Folks, It’s now over 5 weeks since I had surgery to remove a ruptured spleen....
Good news
I am just back from OSU and my visit with Dr. Byrd. Labs were good for the most ...
Want to take advantage of all our features? Just log in!
or
Exercise is the best medicine after surgery or cancer treatment. Introducing a new field of study "Exercise Oncology Research".
The exercise clinic is actually co-located with the chemotherapy or radiation th...
Ibrutinib produces rapid and endurable responses. PFS and DOR not reached at up to 44 months -Steven Coutre's Lymphoma & Myeloma 2015 update
'Long-term follow-up of single-agent ibrutinib at the approved dose of 420 mg da...
Reprogramming the immune system - the potential for a combined approach with checkpoint inhibitors and immune signal activators
Not specific to CLL, but to NHL and HL lymphomas, specifically DLBCL:
"Dr Ansell...
The search continues for additional targets in CLL - an introduction to Axl receptor tyrosine kinase and its inhibitor TP-0903
"Despite enormous advances in therapies for chronic lymphocytic leukemia (CLL) t...
Imbruvica adverse effects.
Dr.Richard Furman and Dr. Jennifer Brown MD PHd explain adverse effects of Imbru...
Venetoclax (ABT-199) response rate on del 17p CLL patients (ASH 2015)
"Patients with CLL harboring 17p deletion [del(17p)] are considered to have very...
You’ve been asked to have your say on NHS England. You just don’t know about it.
Members in England have 3 days (until 23rd November) remaining in which to provi...
Chairman's letter to members - The outcome and next steps - CLLSA Campaign on delisting of CLL drugs from the Cancer Drugs Fund
Thank you to all our members who supported the CLLSA Campaign to appeal against ...